Huang L et al. |
15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model. |
2015 |
Biomed Res Int |
pmid:26844229
|
Li P et al. |
[Effect of peroxisome proliferator-activated receptor-γ on endothelial cells oxidative stress induced by Porphyromonas gingivalis]. |
2015 |
Beijing Da Xue Xue Bao |
pmid:26679661
|
Li XY et al. |
15-Deoxy-prostaglandin J2 anti-inflammation in a rat model of chronic obstructive pulmonary disease and human bronchial epithelial cells via Nrf2 activation. |
2015 |
Genet. Mol. Res. |
pmid:26535717
|
Xu X et al. |
Effect of Salusin-β on Peroxisome Proliferator-Activated Receptor Gamma Gene Expression in Vascular Smooth Muscle Cells and its Possible Mechanism. |
2015 |
Cell. Physiol. Biochem. |
pmid:26279448
|
Gao D et al. |
Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells. |
2015 |
PLoS ONE |
pmid:25874449
|
Maier NK et al. |
The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. |
2015 |
J. Immunol. |
pmid:25681332
|
Wall SB et al. |
Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog. |
2015 |
Redox Biol |
pmid:25677088
|
Meng Y et al. |
Angiotensin II-induced Egr-1 expression is suppressed by peroxisome proliferator-activated receptor-γ ligand 15d-PGJ₂ in macrophages. |
2015 |
Cell. Physiol. Biochem. |
pmid:25591955
|
Penas F et al. |
Treatment in vitro with PPARα and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice. |
2015 |
Biochim. Biophys. Acta |
pmid:25557389
|
Hyun J et al. |
Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk. |
2015 |
J Innate Immun |
pmid:25171731
|
Fang M et al. |
Activation of Human Peroxisome Proliferator-Activated Nuclear Receptors (PPARγ1) by Semi-Volatile Compounds (SVOCs) and Chemical Mixtures in Indoor Dust. |
2015 |
Environ. Sci. Technol. |
pmid:26172262
|
Kim KR et al. |
15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. |
2015 |
PLoS ONE |
pmid:25859665
|
Korolczuk A et al. |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity. |
2014 |
J. Physiol. Pharmacol. |
pmid:25554991
|
Korbecki J et al. |
Cyclooxygenase pathways. |
2014 |
Acta Biochim. Pol. |
pmid:25343148
|
Savinainen JR et al. |
Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A). |
2014 |
PLoS ONE |
pmid:25290914
|
Paakinaho V et al. |
Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation. |
2014 |
Mol. Cell. Biol. |
pmid:24980431
|
Liu C et al. |
15d-PGJâ‚‚ decreases PGEâ‚‚ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter. |
2014 |
Biochem. Pharmacol. |
pmid:25108236
|
Kumar AP et al. |
Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. |
2014 |
Antioxid. Redox Signal. |
pmid:23964924
|
Yin Y et al. |
PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages. |
2014 |
Respir. Res. |
pmid:24612634
|
Heiss EH et al. |
Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorata. |
2014 |
J. Nat. Prod. |
pmid:24476568
|